Quent Capital, LLC Biofrontera Inc. Transaction History

Quent Capital, LLC

  • $950 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Jun 14, 2024
BUY
$0.56 - $1.02 $1,000 - $1,822
1,787 New
1,787 $1,000
Q4 2022

Jan 19, 2023
BUY
$0.77 - $24.8 $1,375 - $44,317
1,787 New
1,787 $0

About Biofrontera Inc.

BFRI Quotes by TradingView
  • Ticker BFRI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 23,551,000
  • Market Cap $22.6M
  • Description
  • Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for phot...
More about BFRI
Track This Portfolio

Track Quent Capital, LLC Portfolio

Follow Quent Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quent Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quent Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email